1-methoxy-canthin-6-one

can represent a candidate for in vivo studies of monotherapies or combined antineoplastic therapies; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Ammirante, Massimo: 1 article (04/2006)
2.	Belisario, Maria Antonietta: 1 article (04/2006)
3.	De Feo, Vincenzo: 1 article (04/2006)
4.	De Martino, Laura: 1 article (04/2006)
5.	Di Giacomo, Rita: 1 article (04/2006)
6.	Festa, Michela: 1 article (04/2006)
7.	Gentilella, Antonio: 1 article (04/2006)
8.	Leone, Arturo: 1 article (04/2006)
9.	Pascale, Maria Carmela: 1 article (04/2006)
10.	Rosati, Alessandra: 1 article (04/2006)

1.	Thyroid Neoplasms (Thyroid Cancer) 04/15/2006 - "We investigated the effects of 1-methoxy-canthin-6-one, isolated from the medicinal plant Ailanthus altissima Swingle, on apoptosis in human leukemia (Jurkat), thyroid carcinoma (ARO and NPA), and hepatocellular carcinoma (HuH7) cell lines. "
2.	Leukemia 04/15/2006 - "We investigated the effects of 1-methoxy-canthin-6-one, isolated from the medicinal plant Ailanthus altissima Swingle, on apoptosis in human leukemia (Jurkat), thyroid carcinoma (ARO and NPA), and hepatocellular carcinoma (HuH7) cell lines. "
3.	Hepatocellular Carcinoma (Hepatoma) 04/15/2006 - "We investigated the effects of 1-methoxy-canthin-6-one, isolated from the medicinal plant Ailanthus altissima Swingle, on apoptosis in human leukemia (Jurkat), thyroid carcinoma (ARO and NPA), and hepatocellular carcinoma (HuH7) cell lines. "